NYSE:DNALife Sciences
Ginkgo Bioworks Holdings (DNA) TTM Net Loss Of US$312.8 Million Reinforces Bearish Narratives
Ginkgo Bioworks Holdings (DNA) has wrapped up FY 2025 with fourth quarter revenue of about US$33.4 million and a basic EPS loss of US$1.41, alongside a net income loss of US$80.8 million. The company has seen trailing twelve month revenue move from US$227.0 million in Q4 2024 to US$170.2 million in Q4 2025. Over the same period, trailing EPS has shifted from a loss of US$10.54 to a loss of US$5.64, indicating that the business is still absorbing heavy costs even as losses on a per share basis...